Aiding innovation in biopharmaceuticals and glycoscience with glycan production and chemical glycosylation
For our activities and events in Japan → @GlyTech_JP
And our accompanying Lead Discovery Service:
Quickly turn your targets into peptide leads with development potential!
✅ Diverse functionality coverage
✅ Initial hits validated in 2–3 months
✅ Expert optimization options
✅ Flexible partnership models
https://t.co/URtw2B3nYA
✨New on our website:
Combining natural peptide scaffolds & our proprietary high efficiency "In Vitro Evolution" system for faster, smarter peptide discovery!
🎯 Target-driven
🔬 Vast screenable space
🤸 High screening criteria flexibility
More info: https://t.co/jZQtPU1tQT
GlyTech, Inc. has been featured in this video created by the Public Relations Office of the Cabinet Office.
We're proud to be one of the many biotech ventures contributing to the Kansai region's drug discovery ecosystem.
Osaka, Kyoto, and Kobe—known as popular tourist destinations in Japan’s Kansai region— are also emerging as drug discovery hubs 💊. Kansai is becoming a key center in Japan’s drug discovery ecosystem, built on each city’s strengths. Learn more about its appeal and progress 👀
本日から福岡で開催される10th Modern Solid Phase Peptide Synthesis & Its Applications Symposium (#SPPS2025)にて企業展示に出展いたします。
皆様のお越しをお待ちしております!
↓イベント詳細↓
https://t.co/X79cmiMhPT
As a supplier of high-quality N-glycan products for glycopeptide SPPS and other glycosylation methods, we're proud to be sponsoring the 10th Modern Solid Phase Peptide Synthesis & Its Applications Symposium in Fukuoka on 24-25 October!
Register at: https://t.co/qolp1RkSzp
We're at #BioJapan!
Join us between today and Friday at C-73, our joint booth with KH Neochem, where alongside our core glycan technologies, we're introducing our antibody-related services, proprietary pipeline, and novel nose-to-brain delivery technology.
We're excited to be attending #BIOEurope in Vienna, Austria, Nov 3–5!
Connect with us to learn how our nose-to-brain delivery system, peptide discovery platform, and glycans could accelerate your discovery efforts. We'll also be promoting our P2 biobetter glycosomatostatin.
We're excited to be back at #BioJapan2025 next week!
Meet us at booth C-73 or find us on the partnering system to schedule a meeting.
https://t.co/R5xaJdzVQk
We're back in Yokohama next month for #BioJapan2025!
We'll be showcasing our novel nose-to-brain drug delivery platform, glycopeptide hormone pipeline, and glycan reagents.
Visit our booth at C-73 or set up a partnering meeting to learn more.
https://t.co/1h8qRsguqZ
We're back in Yokohama next month for #BioJapan2025!
We'll be showcasing our novel nose-to-brain drug delivery platform, glycopeptide hormone pipeline, and glycan reagents.
Visit our booth at C-73 or set up a partnering meeting to learn more.
https://t.co/1h8qRsguqZ
We'll be at BIO Asia-Taiwan this week to introduce our advanced peptide discovery platforms and wide-ranging glycan capabilities.
Find us on the partnering platform or contact us to set up a meeting. Looking forward to connecting in Taipei!
https://t.co/3kFZhUdAv2
At @Eurocarb22 this week? We're looking forward to meeting you in person! Stop by the GlyTech, Inc. & KH Neochem booth to talk glycan reagents and glycopeptide synthesis.
We're looking forward to great glycoscience in Gdańsk at @Eurocarb22 from July 6-10! We're proud to be a sponsor this year alongside our colleagues KH Neochem. See you there!
https://t.co/WrQEN2bxdA
Interested in making your own glycoRNA? GlyTech, Inc. can provide glycosyl-acp3 with your desired glycan structure. Please contact us to learn more.
https://t.co/sFddXqjVut
In collaboration with @Hoshi_univ, we're proud to report the first synthesis of glycosylated acp3U, with & without sialic acid.
This work is expected to enable the synthesis of diverse glycoRNAs for future studies and potential medical applications.
https://t.co/LLELdDfEBT
In collaboration with @Tohoku_mpu, we've published a complete 1H & 13C NMR signal assignment of the G1M9 glycan in Carbohydrate Research!
This work overcomes key glycan analysis challenges & is expected to aid future glycoprotein biosynthesis studies.
https://t.co/hXeNDQYbCQ
#ChemBioChem Conjugation of Human N-Glycans Improves the Drug Properties of Existing Peptides and Proteins (Hirofumi Ochiai and co-workers) @GlyTech, @GlyTech_JP • https://t.co/3S8gRYGOcc
🚀We're thrilled to start our new partnership with @OBIPharma! OBI's glycan-based GlycOBI® platform creates ADCs with improved efficacy & stability. GlyTech will promote GlycOBI in Japan, and enhance our production & supply of GlycOBI-compatible glycans.
📢https://t.co/oD9Q1p6nFE
#BioJapan2024 is over for another year - thank you to everyone who met with us or visited the GlyTech, Inc. and KH Neochem booth this year, whether rain or shine. We look forward to seeing you again!
We're back in Yokohama next month for #BioJapan2024!
This year we're proud to showcase our new brain drug delivery technology.
Visit D85 or contact us to learn more, or about our advanced peptide discovery, glycan reagents and glycosylation capabilities.
https://t.co/1h8qRsguqZ